Exchange: NASDAQ·Updated 07:30 PM EDT
DCTH logo

DCTH Delcath Systems Inc

$15.83
$0.48
(2.98%)
Today
Closed $15.60
$0.23
(1.47%)
After Hours
EarningsNov 3
Mkt Cap$541.3M
Vol262,284.00

About DCTH

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
40

Bearish Sentiment

How do you feel about DCTH?

Advertisement|Remove ads.